PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Columbia University Medical Center, New York, USA. cme2113@cumc.columbia.edu.\', \'Columbia University Medical Center, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04422-y
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 32513308
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all